Access to this symposium is free, but you must first be a
registered FREE ZONE user of HDCN. If not already an HDCN FREE ZONE user, please
register at this link and select a username and password.
|
|
The educational objectives are:
1. Describe a proactive patient management approach to the treatment of patients with CKD, using the most recent diagnostic and treatment guidelines available to nephrology and other clinical
disciplines.
2. Recognize and discuss the prevalence of CKD and its comorbidities, their clinical implications, and innovative screening programs for identifying CKD and its complications.
3.
Summarize new strategies for the treatment of the anemia of CKD and the effects of anemia correction on both cardiac and renal function.
|
Adeera Levin, MD
St Paul's Hospital
University of British Columbia
Vancouver, Canada.
William McClellan, MD
Emory University School of Medicine
Atlanta, GA.
Ajay Singh, MD
Brigham and Women's Hospital
Boston, MA.
Lawrence McMahon, M.D.
Royal Melbourne and Western Hospitals
Melbourne, Victoria, Australia
|
|  |
| This program is accredited
for 1.5 CME credit hours by the American Society of
Nephrology and for 1.5 CE Contact Hours for nurses by the Renal Education Association.
|
| | Date of Original Release: February 1, 2003
CME Credit Eligible Through: May 1, 2004
CME/CE Estimated Completion Time: 1.5 hours
Target Audiences:
Nephrologists, internists, general practicioners, and nurses treating patients with CKD.
Method of participation: Listen to the
talks, read the
PubMed abstracts linked to data slides and talk references, take
the post-test, read the post-test answer feedback material, and complete the
evaluation form. CME/CE certificates are provided on-line after completion.
|
Chronic kidney disease affects 30-40 million Americans, of
whom several
thousand require renal replacement therapy. These selected lectures
are chosen
by the HDCN editor and ASN Postgraduate Medical Director to reflect
those areas
of practice of greatest interest to the clinician, and areas where
recent progress
has occurred. The web extension of these ASN lectures will
allow nephrologists
and other physicians who were unable to attend the live sessions to
gain similar
benefit from these presentations.
| ACCREDITATION
STATEMENTS: |
The American Society of Nephrology is accredited by
the Accreditation
Council for Continuing Medical Education to provide continuing
medical education
for physicians.
The Renal Education Association is accredited by the State of California Board of Nursing to provide continuing education for nurses (provider number: CEP 13092).
The American Society of Nephrology designates this
educational activity
for category 1.5 credits toward the AMA Physician's Recognition Award.
Each physician
should claim only those hours of credit that he/she actually spent
in the activity.
This official ASN symposium was sponsored by a restricted educational grant from Ortho Biotech Products, LP.
| FACULTY DISCLOSURE
STATEMENTS : |
American Society of Nephrology, the Renal Education
Association, as well
as HDCN have conflict of interest policies that requires course
faculty to disclose
any real or apparent commercial financial affiliations related to
the content
of their presentations/materials. It is not assumed that these
financial interests
or affiliations will have an adverse impact on faculty
presentations; they are
simply noted here to fully inform participants.
Dr. Levin: Has grants, research support, consultantships, board positions or honoraria from: Ortho Biotch Products, L.P., Amgen, Genzyme, Roche, and Merck
Dr. McClellan: is a clinical investigator for Ortho Biotech Products, L.P.
Dr. Singh: Has grants, research support, consultantships, board positions, or honoraria from: Ortho Biotech Products, L.P., CHOIR Study Principal Investigator, Pfizer, DCI Medical Director and
Sherine Medical. He is also a scientific
advisor for FlowMedica and Sherine Medical.
Dr. McMahon: Has grants, research support, or honoraria from: Janssen-Cilag, Ortho Biotech Products, L.P. and Amgen. He is also a scientific advisor for Janssen-Cilag and Ortho Biotech Products,
L.P.
| DISCLOSURE OF
UNLABELED USE: |
This educational activity may contain discussion of
published and/or
investigational uses of agents that are not indicated by FDA. The
American Society
of Nephrology, the Renal Education Association, and HDCN do not
recommend the
use of any agent outside of the labeled indications. Please refer
to the official
prescribing information for each product for discussion of approved
indications,
contraindications and warnings.
Participants have an implied responsibility to use the
newly acquired
information to enhance patient outcomes and their own professional
development.
The information presented in this activity is not meant to serve as
a guideline
for patient management. Any procedures, medications, or other
courses of diagnosis
or treatment discussed or suggested in this activity should not be
used by clinicians
without evaluation of their patient's conditions and possible
contraindications
on dangers in use, review of any applicable manufacturer's product
information,
and comparison with recommendations of other authorities.
To complete this educational activity, the user will need Windows or Macintosh operating
software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have
an audio card with speakers. An audio player, either the Windows Media Player from Microsoft or
the Real Player from Real Media (www.real.com) is required and either can be downloaded for free
per instructions on the individual lecture pages. Acrobat Reader is required to print the CME or
CE certificate, and this can be download free from www.adobe.com.
For any questions concerning this activity please send an email to 
or call HDCN at 630-325-3276.
| |
